Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective

Similar documents
TB Contact Investigation

Using Xpert to discontinue airborne isolation The Consensus Statement

TB Control in Finland - the role of THL

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB in Corrections Phoenix, Arizona

TB Update: March 2012

Tuberculosis Epidemiology

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

TUBERCULOSIS CONTACT INVESTIGATION

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

New Tuberculosis Guidelines. Jason Stout, MD, MHS

Stacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona

Utilizing All the Tools in the TB Toolbox

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

TUBERCULOSIS CONTACT INVESTIGATION

Contact Investigation

Northwestern Polytechnic University

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010

Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis

Case Presentations Part 2

Ken Jost, BA, has the following disclosures to make:

Interpretation of TST & IGRA results. Objectives

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Tuberculosis Tools: A Clinical Update

California TB program updates

Revised Technical Instructions for Civil Surgeons. October 9, 2018

Diagnosis and Medical Management of Latent TB Infection

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None

Receipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California

Core Curriculum on Tuberculosis: What the Clinician Should Know

TB BASICS: PRIORITIES AND CLASSIFICATIONS

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Outline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity

Diagnosis of Tuberculosis Infection and Disease

TB 101 Disease, Clinical Assessment and Lab Testing

TB in the Patient with HIV

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex

Dr Francis Ogaro MTRH ELDORET

2017/2018 Annual Volunteer Tuberculosis Notice

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

Experts on Xpert: A laboratorian and a clinician discuss interpretation of Xpert MTB/RIF Results

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Clinical Practice Guideline

Diagnosis Latent Tuberculosis. Disclosures. Case

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Tuberculosis Elimination

Please distribute a copy of this information to each provider in your organization.

Fundamentals of Tuberculosis (TB)

TB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012

Arizona Annual Tuberculosis Surveillance Report

NAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

TUBERCULOSIS. Pathogenesis and Transmission

Chapter 4 Diagnosis of Tuberculosis Disease

Pediatric TB Intensive Houston, Texas October 14, 2013

INDEX CASE INFORMATION

What s New in TB Infection Control?

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

Asking the Right Questions. A Visual Guide to Tuberculosis Case Management for Nurses. Reference Guide

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012

When Can Isolation Be Discontinued?

TB in California: Costs, Transmission, and Selecting from the Latent Pool

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Tuberculosis Intensive

2016 Annual Tuberculosis Report For Fresno County

The diagnosis of active TB

TB BASICS: PRIORITIES AND CLASSIFICATIONS

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

TB the basics. (Dr) Margaret (DHA) and John (INZ)

Role of the Laboratory in TB Diagnosis and Management

TB Nurse Case Management Davenport, Iowa September 27 28, 2011

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing

TB Classification (ATS/CDC)

Making the Diagnosis of Tuberculosis

Tuberculosis Populations at Risk

Diagnosing TB in HIV Co- infected PaAents

Epidemiology of Tuberculosis Denver TB Course

Step 1. CDC Framework for Program Evaluation. Stakeholders Maryland Evaluation Team. Identify Stakeholders

Haley Blake Sage Nagai, MPH. Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

Nucleic Acid Amplification Testing for the Diagnosis of TB

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

At the end of this session, participants will be able to:

Peggy Leslie-Smith, RN

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Transcription:

Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective James Watt, MD, MPH Acting Chief, Tuberculosis Control Branch California Department of Public Health

3 Aspects

The use of rapid, accurate mycobacteriology laboratory services and the prompt reporting of results to providers and the local health departments are essential to the control of tuberculosis. CDPH/CTCA/CAPHLD Joint Guidelines for Mycobacteriology Services in California, 1998/2008

Public health laboratories should: assess and monitor the competence of laboratories that perform any testing related to TB within their jurisdictions; develop guidelines for reporting and tracking of laboratory results; educate health care providers, and public health officials about available laboratory tests, new technologies, and indications for their use. ATS/CDC/IDSA. Controlling Tuberculosis in the United States. Am J Resp Crit Care Med. 2005;172:1170-1218.

Effective TB control depends on an integrated system that includes clinicians, laboratorians, and TB-control officials. CDC/APHL. National Plan for Reliable Tuberculosis Laboratory Services Using a Systems Approach. MMWR 2005;54(RR-6).

General Characteristics The possibility of drug resistance increases the importance of making rapid and accurate diagnoses. Important characteristics for laboratory services rapid accurate (sensitivity and specificity)

Factors that Influence Rapidity and Accuracy Laboratory systems specimen shipping turn around times information systems Specific tests active TB delay in diagnosis could result in transmission of drug resistant disease latent TB infection (LTBI) treatment decisions for MDR exposure difficult

Diagnosis of Active TB--Scenario 45 yo recent immigrant from Philippines previously treated for TB presents with 10 days of cough and fever CXR: RUL scarring RML infiltrate Sputum smear negative

Diagnosis of Active TB Essential Services Assessment: TB or non-tb pneumonia? high risk for drug resistant TB Problem: possible transmission of drug resistant TB Objective: rapid, accurate diagnosis Important tests: fluorescent microscopy nucleic acid amplification tests selective, liquid culture system nucleic acid probes to identify M. tb complex

Diagnosis of LTBI--Scenario 17 yo high school student Culture confirmed MDR-TB Smear positive, cavitary CXR Urban high school >3,000 students 40% students foreign born

Diagnosis of LTBI Essential Services Problem: high background TST positivity difficulty in assessing transmission difficulties of treatment after MDR exposure Objective: increase the specificity of LTBI diagnosis Important test: IGRA

Services Specific to Drug Resistance Critical characteristics: rapid accurate Important tests: rapid, molecular diagnosis broth based first line susceptibility standardized second line susceptibility

Other Important Tests Clinical monitoring of MDR-TB patients drug levels tests for toxicity Genotyping

Example of Consultation Annual testing employees (n=300) TST used in past (few positives) IGRA implemented 9% positive 7% indeterminate Collaborative investigation revealed high nil levels Repeat tests negative Gamsky TE and Alexander RC. J Occup Environ Med 2008;50:3-4.

Consultation Private laboratories reporting and specimen submission quality assurance Clinicians appropriate testing interpretation of results resolution of complex situations TB control program efficiency prioritization

Summary 3 Aspects Importance of rapid and accurate laboratory services for TB control Specific tests related to drug resistance Consultative role of Public Health Laboratories Dialogue about creating an efficient and effective system for TB control

End Here

Essential Mycobacteriology Laboratory Services General tests fluorescent microscopy NAAT broth culture system IGRA Consultation Susceptibility tests rapid, molecular diagnosis broth based first line susceptibility standardized second line susceptibility (reference)

Prompt, accurate diagnosis and effective treatment are not only essential for good patient care they are the key elements in the public health response to tuberculosis and the cornerstone of tuberculosis control. International Standards for Tuberculosis Care, 2006.